• Product NameRPI-1
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityRPI-1 reduced the phosphorylation of RET, MET, DCDB2, CTND1, and PLCγ
• Target Namec-Met/HGFR inhibitor; c-RET; Others; Phospholipase
• CAS No. 269730-03-2
• Calculated MW 297.31
• Formulation C17H15NO4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:COC1=C(C=C2C(=C1)/C(=C/C3=CC=C(C=C3)O)/C(=O)N2)OC
  Pathways:Apoptosis; Metabolism; Others; Tyrosine Kinase/Adaptors
  Receptor:Met; RET; CTND1; DCDB2; PLCγ
  Boling pt:
  Melting pt:
  Solubility:DMSO: 10 mM
  Appearance:Yellowish-brown Solid
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Petrangolini G, et al. Biochem Pharmacol. 2006 Aug 14;72(4):405-14. 2. Caccia D, et al. Mol Y. 2010 Oct 18;9:278.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting